Larimar Therapeutics, Inc. Deferred Tax Assets, Operating Loss Carryforwards
Financial Statements › Balance Sheet › Assets › Components of Deferred Tax Assets › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsOperatingLossCarryforwards · last filed 2026-03-19
- 2025-12-31: Deferred Tax Assets, Operating Loss Carryforwards $93.10M.
- 2024-12-31: Deferred Tax Assets, Operating Loss Carryforwards $50.18M.
- 2023-12-31: Deferred Tax Assets, Operating Loss Carryforwards $45.20M.
- 2022-12-31: Deferred Tax Assets, Operating Loss Carryforwards $42.20M.
| Period end | Deferred Tax Assets, Operating Loss Carryforwards | Deferred Tax Assets, Operating Loss Carryforwards as first filed |
|---|---|---|
| 2025-12-31 | $93.10M 10-K · filed 2026-03-19 | |
| 2024-12-31 | $50.18M 10-K · filed 2026-03-19 | |
| 2023-12-31 | $45.20M 10-K · filed 2025-03-24 | |
| 2022-12-31 | $42.20M 10-K · filed 2024-03-14 | |
| 2021-12-31 | $43.22M 10-K · filed 2023-03-14 | |
| 2020-12-31 | $32.08M 10-K · filed 2022-03-25 | |
| 2019-12-31 | $10.98M 10-K · filed 2021-03-04 | $19.76M 10-K · filed 2020-03-05 |
| 2018-12-31 | $16.73M 10-K · filed 2020-03-05 | |
| 2017-12-31 | $13.85M 10-K · filed 2019-03-14 | |
| 2016-12-31 | $14.99M 10-K · filed 2018-03-09 | |
| 2015-12-31 | $11.19M 10-K · filed 2017-03-10 | |
| 2014-12-31 | $6.33M 10-K · filed 2016-03-15 | $6.28M 10-K · filed 2015-03-25 |
| 2013-12-31 | $4.02M 10-K · filed 2015-03-25 |